Elromo 25mg Tablet

1. Product Introduction

Elromo 25mg Tablet is a prescription medication that contains Eltrombopag (25mg) as its active ingredient. Eltrombopag is a thrombopoietin receptor agonist designed to treat conditions associated with low platelet counts (thrombocytopenia). Platelets are essential for blood clotting, and a deficiency can result in excessive bleeding or bruising. Elromo works by stimulating the bone marrow to produce more platelets.

This medicine is mainly used in patients with chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia. It is especially beneficial for individuals who have not responded adequately to other treatments such as corticosteroids, immunoglobulins, or surgery (e.g., splenectomy). Elromo 25mg comes in tablet form and is meant for oral administration under medical supervision.

Regular monitoring of blood counts and liver function is crucial during treatment. The dosage may be adjusted based on the patient’s response and any side effects. Elromo 25mg provides a non-invasive, convenient option to manage low platelet counts effectively.

2. Uses of This Medicine

Elromo 25mg Tablet is used for treating:

• Chronic Immune Thrombocytopenia (ITP):
  In patients aged 1 year and older who have not responded to first-line treatments like corticosteroids or immunoglobulin therapy. ITP is an autoimmune disorder where the immune system destroys platelets.

• Thrombocytopenia Associated with Hepatitis C:
  To increase platelet counts in patients undergoing interferon-based therapy for hepatitis C, enabling them to continue or initiate antiviral treatment.

• Severe Aplastic Anemia (SAA):
  For patients with SAA who have had an insufficient response to immunosuppressive therapy, or as a first-line treatment in combination with other agents.

3. Benefits of This Medicine

• Increases Platelet Production:
  Elromo stimulates thrombopoietin receptors in the bone marrow, helping the body generate more platelets naturally.

• Reduces Bleeding Risk:
  By improving platelet counts, it reduces the risk of internal bleeding and bruising, particularly in ITP and aplastic anemia patients.

• Improves Quality of Life:
  Patients with chronic low platelet levels often face fatigue and lifestyle restrictions. Elromo improves symptoms and supports normal daily activities.

• Enables Antiviral Therapy in Hepatitis C:
  Many hepatitis C patients with thrombocytopenia cannot undergo interferon treatment. Elromo helps maintain sufficient platelet levels for therapy.

• Oral Dosage Form:
  It offers the convenience of an oral tablet, eliminating the need for hospital visits for injectable treatments.

• Effective for Refractory Cases:
  Particularly useful in patients who do not respond to other standard treatments, offering a new line of therapy.

4. Side Effects

Like all medications, Elromo 25mg may cause side effects, although not everyone experiences them. Side effects can range from mild to severe and should be promptly reported to a healthcare provider.

Common Side Effects:

• Headache

• Nausea

• Fatigue

• Diarrhea

• Muscle pain

• Fever

• Cough or sore throat (especially in children)

Serious Side Effects:

• Liver Function Issues: Elevated liver enzymes; requires regular liver monitoring.

• Thromboembolic Events: Risk of blood clots if platelet counts become too high.

• Cataracts: Risk increases with long-term use; regular eye checkups are advised.

• Bone Marrow Fibrosis: Rare but serious condition where scar tissue builds up in the bone marrow.

Precautions:

• Should not be taken with dairy products, calcium supplements, or antacids as these may reduce absorption.

• Regular monitoring of platelet counts, liver function tests, and eye examinations is essential.

• Use in pregnancy and breastfeeding should be done only if clearly needed and under medical supervision.

5. Frequently Asked Questions (FAQ)

Q1. How does Elromo 25mg Tablet work?
Elromo activates thrombopoietin receptors in the bone marrow, stimulating the production of new platelets and increasing their levels in the bloodstream.

Q2. Can Elromo cure ITP or aplastic anemia?
No, Elromo is not a cure. It helps manage symptoms by increasing platelet counts and reducing bleeding risk. Continued monitoring and treatment may be necessary.

Q3. When should I take this tablet – with or without food?
Take Elromo on an empty stomach, at least 1 hour before or 2 hours after meals. Avoid consuming dairy, antacids, or supplements containing calcium around the time of taking the medicine.

Q4. How long do I need to take Elromo?
The duration of treatment varies based on your condition and response. Your doctor will decide the appropriate treatment duration and adjust the dose accordingly.

Q5. What should I do if I miss a dose?
If you forget a dose, take it as soon as you remember unless it’s almost time for your next dose. Do not double the dose to make up for a missed one.

References